3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Neoplasm Metastasis
5
Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
HER2-positive Breast Cancer
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Patient Preference
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Inflammatory Breast Neoplasms
1
Interventions
Methotrexate
6
Cyclophosphamide
6
ponatinib
5
Cytarabine
5
merphos
4
Mycophenolic Acid
4
blinatumomab
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporine
3
venetoclax
2
fludarabine phosphate
2
bosutinib
2
Vincristine
2
Rituximab
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Idarubicin
2
Etoposide
2
Cladribine
2
CT-P10
2
Busulfan
2
prednylidene
1
pegfilgrastim
1
nilotinib
1
midostaurin
1
gilteritinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
Ado-Trastuzumab Emtansine
×
1 year
×
Clear all
No trials found.